Golden
Biosergen

Biosergen

A synthetic biology company developing drugs using biosynthetic engineering and natural products.

All edits

Edits on 24 Sep 2019
Dawson Sewell
Dawson Sewell edited on 24 Sep 2019 2:34 pm
Edits made to:
Article (+1088 characters)
Topic thumbnail

Biosergen

A synthetic biology company developing drugs using biosynthetic engineering and natural products.

Article

Biosergen is a synthetic biology company developing drugs using biosynthetic engineering and natural products that is headquartered in Trondheim, Norway and was founded in 2004 by Anders Kronström. The company was founded based on the potential of synthetic biology inventions for the bioengineering of products combined with chemical synthesis made at the Norwegian University of Science and Technology (NTNU) and SINTEF. 



On September 1, 2017 Peder M. Anderson became the CEO of Biosergen, replacing the CEO and founder Anders Kronström. 

Funding

Grant

On February 12, 2016 Biosergen received a grant for the BIA innovation reward from the Research Council of Norway. Biosergen was one on 50 companies awarded the grant. At the time of funding the CEO of Biosergen, Anders Kronström, made the following comment regarding the grant funding: 

This innovation grant means a lot for our research and also for patients worldwide suffering from diseases caused by systemic fungal infections. It will directly strengthen our opportunities to turn our innovation efforts into improved treatments. 
Edits on 9 Sep 2019
Dawson Sewell
Dawson Sewell edited on 9 Sep 2019 1:05 pm
Edits made to:
Infobox (+5 properties)
Description (+98 characters)
Topic thumbnail

Biosergen

A synthetic biology company developing drugs using biosynthetic engineering and natural products.

Infobox

Dawson Sewell"Initial topic creation"
Dawson Sewell created this topic on 9 Sep 2019 1:01 pm
Edits made to:
Topic thumbnail

 Biosergen

A synthetic biology company developing drugs using biosynthetic engineering and natural products.

No more activity to show.